FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1536792806> ?p ?o ?g. }

• W1536792806 endingPage "1061" @default.
• W1536792806 startingPage "1053" @default.
• W1536792806 abstract "We previously reported a contemporaneous onset of cancer and scleroderma in patients with anti-RNA polymerase III antibodies, and we identified a biologic link between cancer and scleroderma. This investigation was designed to further evaluate whether autoantibody status and other characteristics are associated with cancer and a clustering of cancer with scleroderma onset.Logistic regression analysis was performed to assess the relationship of 2 outcomes, cancer (model 1) and a short (±2 years) cancer-scleroderma interval (model 2), with autoantibody status and scleroderma covariates.Of 1,044 scleroderma patients, 168 (16.1%) had cancer. In the adjusted model 1, only older age at scleroderma onset (odds ratio 1.04 [95% confidence interval 1.02-1.05]) and white race (odds ratio 2.71 [95% confidence interval 1.22-6.04]) were significantly associated with an increased overall risk of cancer. In the adjusted model 2, only anti-RNA polymerase III positivity (odds ratio 5.08 [95% confidence interval 1.60-16.1]) and older age at scleroderma onset (odds ratio 1.04 [95% confidence interval 1.00-1.08]) were significantly associated with a short cancer-scleroderma interval. While anti-RNA polymerase III positivity was associated with a short cancer-scleroderma interval independent of age at scleroderma onset, the cancer-scleroderma interval shortened with older age at scleroderma onset in other antibody groups (Spearman's correlation P < 0.05), particularly among patients with anti-topoisomerase I antibodies and patients who were negative for anticentromere, anti-topoisomerase I, and anti-RNA polymerase III antibodies.Increased age at scleroderma onset is strongly associated with cancer risk overall. While anti-RNA polymerase III status is an independent marker of coincident cancer and scleroderma at any age, a clustering of cancer with scleroderma is also seen in patients with anti-topoisomerase I and other autoantibody specificities who develop scleroderma at older ages." @default.
• W1536792806 created "2016-06-24" @default.
• W1536792806 creator A5000610272 @default.
• W1536792806 creator A5004540531 @default.
• W1536792806 creator A5008833389 @default.
• W1536792806 creator A5009211703 @default.
• W1536792806 creator A5068528030 @default.
• W1536792806 creator A5089826071 @default.
• W1536792806 date "2015-03-27" @default.
• W1536792806 modified "2023-10-16" @default.
• W1536792806 title "Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer-Associated Scleroderma" @default.
• W1536792806 cites W1262308645 @default.
• W1536792806 cites W1541812013 @default.
• W1536792806 cites W1546712514 @default.
• W1536792806 cites W1736835472 @default.
• W1536792806 cites W1964592252 @default.
• W1536792806 cites W2013968350 @default.
• W1536792806 cites W2023946136 @default.
• W1536792806 cites W2024346357 @default.
• W1536792806 cites W2028921539 @default.
• W1536792806 cites W2050516496 @default.
• W1536792806 cites W2084554507 @default.
• W1536792806 cites W2108678383 @default.
• W1536792806 cites W2119560279 @default.
• W1536792806 cites W2157488331 @default.
• W1536792806 cites W2161082940 @default.
• W1536792806 cites W2161603955 @default.
• W1536792806 cites W2165416097 @default.
• W1536792806 cites W2165911231 @default.
• W1536792806 cites W2299513640 @default.
• W1536792806 cites W4431675 @default.
• W1536792806 doi "https://doi.org/10.1002/art.39022" @default.
• W1536792806 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4400658" @default.
• W1536792806 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25605296" @default.
• W1536792806 hasPublicationYear "2015" @default.
• W1536792806 type Work @default.
• W1536792806 sameAs 1536792806 @default.
• W1536792806 citedByCount "87" @default.
• W1536792806 countsByYear W15367928062015 @default.
• W1536792806 countsByYear W15367928062016 @default.
• W1536792806 countsByYear W15367928062017 @default.
• W1536792806 countsByYear W15367928062018 @default.
• W1536792806 countsByYear W15367928062019 @default.
• W1536792806 countsByYear W15367928062020 @default.
• W1536792806 countsByYear W15367928062021 @default.
• W1536792806 countsByYear W15367928062022 @default.
• W1536792806 countsByYear W15367928062023 @default.
• W1536792806 crossrefType "journal-article" @default.
• W1536792806 hasAuthorship W1536792806A5000610272 @default.
• W1536792806 hasAuthorship W1536792806A5004540531 @default.
• W1536792806 hasAuthorship W1536792806A5008833389 @default.
• W1536792806 hasAuthorship W1536792806A5009211703 @default.
• W1536792806 hasAuthorship W1536792806A5068528030 @default.
• W1536792806 hasAuthorship W1536792806A5089826071 @default.
• W1536792806 hasBestOaLocation W15367928061 @default.
• W1536792806 hasConcept C121608353 @default.
• W1536792806 hasConcept C126322002 @default.
• W1536792806 hasConcept C143998085 @default.
• W1536792806 hasConcept C156957248 @default.
• W1536792806 hasConcept C159654299 @default.
• W1536792806 hasConcept C163764329 @default.
• W1536792806 hasConcept C180032290 @default.
• W1536792806 hasConcept C203014093 @default.
• W1536792806 hasConcept C2779967694 @default.
• W1536792806 hasConcept C44249647 @default.
• W1536792806 hasConcept C71924100 @default.
• W1536792806 hasConcept C90924648 @default.
• W1536792806 hasConceptScore W1536792806C121608353 @default.
• W1536792806 hasConceptScore W1536792806C126322002 @default.
• W1536792806 hasConceptScore W1536792806C143998085 @default.
• W1536792806 hasConceptScore W1536792806C156957248 @default.
• W1536792806 hasConceptScore W1536792806C159654299 @default.
• W1536792806 hasConceptScore W1536792806C163764329 @default.
• W1536792806 hasConceptScore W1536792806C180032290 @default.
• W1536792806 hasConceptScore W1536792806C203014093 @default.
• W1536792806 hasConceptScore W1536792806C2779967694 @default.
• W1536792806 hasConceptScore W1536792806C44249647 @default.
• W1536792806 hasConceptScore W1536792806C71924100 @default.
• W1536792806 hasConceptScore W1536792806C90924648 @default.
• W1536792806 hasFunder F4320306828 @default.
• W1536792806 hasFunder F4320337362 @default.
• W1536792806 hasIssue "4" @default.
• W1536792806 hasLocation W15367928061 @default.
• W1536792806 hasLocation W15367928062 @default.
• W1536792806 hasLocation W15367928063 @default.
• W1536792806 hasLocation W15367928064 @default.
• W1536792806 hasOpenAccess W1536792806 @default.
• W1536792806 hasPrimaryLocation W15367928061 @default.
• W1536792806 hasRelatedWork W1843463370 @default.
• W1536792806 hasRelatedWork W1982619745 @default.
• W1536792806 hasRelatedWork W2002325000 @default.
• W1536792806 hasRelatedWork W2042747989 @default.
• W1536792806 hasRelatedWork W2076929529 @default.
• W1536792806 hasRelatedWork W2114056959 @default.
• W1536792806 hasRelatedWork W2167103565 @default.
• W1536792806 hasRelatedWork W2417545465 @default.
• W1536792806 hasRelatedWork W2999586795 @default.
• W1536792806 hasRelatedWork W4225673987 @default.

• next